Top 7 healthcare disruptors, per CNBC

The CNBC Disruptor 50 list for 2024 includes seven healthcare companies.

Advertisement

The news outlet scored the finalists after receiving nominations for companies founded after Jan. 1, 2009, with detailed quantitative and qualitative information.

An advisory board of 50 innovators and entrepreneurs ranked the quantitative criteria for disruption potential, which this year was topped by scalability and user growth, followed by sales growth and use of breakthrough technologies (such as artificial intelligence and machine learning). A group of venture capitalists provided an additional layer of qualitative review.

OpenAI, which has an expanding presence in healthcare through its relationship with Microsoft, came in No. 1 for the second straight year. Here are the healthcare startups that made the May 14 rankings:

8. ElevateBio

17. Transcarent

25. Generate:Biomedicines

29. Alto Pharmacy

45. Spring Health

49. Maven Clinic

50. Cityblock

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Disruptors

  • OpenAI signed its first international hospital partnership with Ramat Gan, Israel-based Sheba Medical Center. The deal, according to a July…

  • Amazon is hiring software and applied-science leaders, AI engineers and a healthcare cybersecurity specialist — the kinds of roles hospital…

Advertisement

Comments are closed.